Role of α-melanocyte stimulating hormone and melanocortin 4 receptor in brain inflammation

Peptides

Volumn 29, Issue 10, 2008, Pages 1825-1835

  Lasaga, Mercedes ^a   Debeljuk, Luciano ^b   Durand, Daniela ^a   Scimonelli, Teresa N ^c   Caruso, Carla ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b SOUTHERN ILLINOIS UNIVERSITY   (United States)

^c UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

MSH; CNS; Inflammation; MC4 receptor

Indexed keywords

[4 CHLOROBENZYL 2 (4-CYCLOHEXYL 4 [1,2,3,]TRIAZOL 1 YLMETHYLPIPERIDIN 1 YL) 2 OXO ETHYL]AMIDE; ALPHA INTERMEDIN; ANTIINFLAMMATORY AGENT; MELANOCORTIN 4 RECEPTOR; RO 273225; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNITY; DRUG MECHANISM; ENCEPHALITIS; GLIA CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ALPHA-MSH; ANIMALS; BRAIN; ENCEPHALITIS; HUMANS; RECEPTOR, MELANOCORTIN, TYPE 4; RECEPTORS, MELANOCORTIN;

EID: 52049094806     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.06.009     Document Type: Review

References (130)

1. Akbulut S., Byersdorfer C.A., Larsen C.P., Zimmer S.L., Humphreys T.D., and Clarke B.L. Expression of the melanocortin 5 receptor on rat lymphocytes. Biochem Biophys Res Commun 281 (2001) 1086-1092
2. Banks W.A., and Kastin A.J. Permeability of the blood-brain barrier to melanocortins. Peptides 16 (1995) 1157-1161
3. Bazzani C., Guarini S., Botticelli A.R., Zaffe D., Tomasi A., Bini A., et al. Protective effect of melanocortin peptides in rat myocardial ischemia. J Pharmacol Exp Ther 297 (2001) 1082-1087
4. Benjannet S., Rondeau N., Day R., Chrétien M., and Sedah N.G. PC1 and PC2 are protein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues. Proc Natl Acad Sci USA 88 (1991) 3564-3568
5. Bhardwaj R.S., Schwarz A., Becher E., Mahnke K., Aragane Y., Schwarz T., et al. Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. J Immunol 156 (1996) 2517-2521
6. Böhm M., Wolff I., Scholzen T.E., Robinson S.J., Healy E., Luger T.A., et al. alpha-Melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J Biol Chem 280 (2005) 5795-5802
7. Boston B.A., and Cone R.D. Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line. Endocrinology 137 (1996) 2043-2050
8. Brod S.A., and Hood Z.M. Ingested (oral) alpha-MSH inhibits acute EAE. J Neuroimmunol 193 (2008) 106-112
9. Caldwell H.K., and Lepri J.J. Disruption of the fifth melanocortin receptor alters the urinary excretion of aggression-modifying pheromones in male house mice. Chem Senses 27 (2002) 91-94
10. Caruso C., Durand D., Schiöth H.B., Rey R., Seilicovich A., and Lasaga M. Activation of melanocortin 4 receptors reduces the inflammatory response and prevents apoptosis induced by lipopolysaccharide and interferon-gamma in astrocytes. Endocrinology 148 (2007) 4918-4926
11. Caruso C., Mohn C., Karara A.L., Rettori V., Watanobe H., Schiöth H.B., et al. Alpha-melanocyte-stimulating hormone through melanocortin-4 receptor inhibits nitric oxide synthase and cyclooxygenase expression in the hypothalamus of male rats. Neuroendocrinology 79 (2004) 278-286
12. Catania A., and Lipton J.M. Alpha-melanocyte stimulating hormone in the modulation of host reactions. Endocr Rev 14 (1993) 564-576
13. Catania A., Gatti S., Colombo G., and Lipton J.M. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev 56 (2004) 1-29
14. Catania A. The melanocortin system in leukocyte biology. J Leukoc Biol 81 (2007) 383-392
15. Chai B., Li J.Y., Zhang W., Newman E., Ammori J., and Mulholland M.W. Melanocortin-4 receptor-mediated inhibition of apoptosis in immortalized hypothalamic neurons via mitogen-activated protein kinase. Peptides 27 (2006) 2846-2857
16. Chaki S., and Okuyama S. Involvement of melanocortin-4 receptor in anxiety and depression. Peptides 26 (2005) 1952-1964
17. Chen A.S., Marsh D.J., Trumbauer M.E., Frazier E.G., Guan X.M., Yu H., et al. Activation of melanocortin type 3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 26 (2000) 97-102
18. Chen D., and Rothenberg E.V. Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles. J Exp Med 179 (1994) 931-942
19. Chen W., Kelly M.A., Opitz-Araya X., Thomas R.E., Low M.J., and Cone R.D. Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell 91 (1997) 789-798
20. Chhajlani V., and Wikberg J.E. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett 309 (1992) 417-420
21. Clarke C.J., Taylor-Fishwick D.A., Hales A., Chernajovsky Y., Sugamura K., Feldmann M., et al. Interleukin-4 inhibits kappa light chain expression and NF kappa B activation but not I kappa B alpha degradation in 70Z/3 murine pre-B cells. Eur J Immunol 25 (1995) 2961-2966
22. Cone R.D. Anatomy and regulation of the central melanocortin system. Nat Neurosci 8 (2005) 571-578
23. Cowley M.A., Pronchuk N., Fan W., Dinulescu D.M., Colmers W.F., and Cone R.D. Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat. Neuron 24 (1999) 155-163
24. Cragnolini A.B., Caruso C., Lasaga M., and Scimonelli T.N. Alpha-MSH and gamma-MSH modulate early release of hypothalamic PGE2 and NO induced by IL-1beta differently. Neurosci Lett 409 (2006) 168-172
25. Dawson T.M., and Ginty D.D. CREB family transcription factors inhibit neuronal suicide. Nat Med 8 (2002) 450-451
26. Delgado R., Carlin A., Airaghi L., Demitri M.T., Meda L., Galimberti D., et al. Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. J Leukoc Biol 63 (1998) 740-745
27. Denef C., Lu J., and Swinnen E. Gamma-MSH peptides in the pituitary: effects, target cells and receptors. Ann N Y Acad Sci 994 (2003) 123-132
28. Dong Y., and Benveniste E.N. Immune function of astrocytes. Glia 36 (2001) 180-190
29. Eberle A.N. The melanotropins: chemistry, physiology, and mechanisms of action (1998), Karger, Basel
30. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., and Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385 (1997) 165-168
31. Farooqi I.S., Yeo G.S., Keogh J.M., Aminian S., Jebb S.A., Butler G., et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 106 (2000) 271-279
32. Forslin Aronsson A., Spulber S., Oprica M., Winblad B., Post C., and Schultzberg M. Alpha-MSH rescues neurons from excitotoxic cell death. J Mol Neurosci 33 (2007) 239-251
33. Galimberti D., Baron P., Meda L., Prat E., Scarpini E., Delgado R., et al. Alpha-MSH peptides inhibit production of nitric oxide and tumor necrosis factor-alpha by microglial cells activated with beta-amyloid and interferon gamma. Biochem Biophys Res Commun 263 (1999) 251-256
34. Gantz I., Konda Y., Tashiro T., Shimoto Y., Miwa H., Munzert G., et al. Molecular cloning of a novel melanocortin receptor. J Biol Chem 268 (1993) 8246-8250
35. Gantz I., Miwa H., Konda Y., Shimoto Y., Tashiro T., Watson S.J., et al. Molecular cloning, expresión, and gene localization of a fourth melanocortin receptor. J Biol Chem 268 (1993) 15174-15179
36. Getting S.J., Allcock G.H., Flower R., and Perretti M. Natural and synthetic agonists of the melanocortin receptor type 3 possess anti-inflammatory properties. J Leukoc Biol 69 (2001) 98-104
37. Getting S.J., and Perretti M. MC3-R as a novel target for antiinflammatory therapy. Drug News Perspect 13 (2000) 19-27
38. Giuliani D., Mioni C., Altavilla D., Leone S., Bazzani C., Minutoli L., et al. Both early and delayed treatment with melanocortin 4 receptor-stimulating melanocortins produces neuroprotection in cerebral ischemia. Endocrinology 147 (2006) 1126-1135
39. Giuliani D., Mioni C., Bazzani C., Zaffe D., Botticelli A.R., Capolongo S., et al. Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage. Br J Pharmacol 150 (2007) 595-603
40. Giuliani D., Ottani A., Mioni C., Bazzani C., Galantucci M., Minutoli L., et al. Neuroprotection in focal cerebral isquemia owing to delayed treatment with melanocortins. Eur J Pharmacol 570 (2007) 57-65
41. Glyn J.R., and Lipton J.M. Hypothermic and antipyretic effects of centrally administered ACTH (1-24) and α-melanotropin. Peptides 2 (1981) 177-187
42. Guarini S., Bazzani C., and Bertolini A. Resuscitating effect of melanocortin peptides after prolonged respiratory arrest. Br J Pharmacol 121 (1997) 1454-1460
43. Guarini S., Cainazzo M.M., Giuliani D., Mioni C., Altavilla D., et al. Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathway. Cardiovasc Res 63 (2004) 357-365
44. Hadley M.E. Discovery that a melanocortin regulates sexual functions in male and female humans. Peptides 26 (2005) 1687-1689
45. Haeffner A., Thieblemont N., Déas O., Marelli O., Charpentier B., Senik A., et al. Inhibitory effect of growth hormone on TNF-alpha secretion and nuclear factor-kappaB translocation in lipopolysaccharide-stimulated human monocytes. J Immunol 158 (1997) 1310-1314
46. Han D., Tian Y., Zhang M., Zhou Z., and Lu J. Prevention and treatment of experimental autoimmune encephalomyelitis with recombinant adeno-associated virus-mediated alpha-melanocyte-stimulating hormone-transduced PLP139-151-specific T cells. Gene Ther 14 (2007) 383-395
47. Haynes W.G., Morgan D.A., Djalali A., Sivitz W.I., and Mark A.L. Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension 33 (1999) 542-547
48. Herz R.C., De Wildt D.J., and Versteeg D.H. The effects of gamma 2-melanocyte-stimulating hormone and nimodipine on cortical blood flow and infarction volume in two rat models of middle cerebral artery occlusion. Eur J Pharmacol 306 (1996) 113-121
49. Hill R.P., Wheeler P., MacNeil S., and Haycock J.W. Alpha-melanocyte stimulating hormone cytoprotective biology in human dermal fibroblast cells. Peptides 26 (2005) 1150-1158
50. Ho H.Y., Lee H.H., and Lai M.Z. Overexpression of mitogen-activated protein kinase reversed cAMP inhibition of NF-kappaB in T cells. Eur J Immunol 27 (1997) 222-226
51. Huang Q., and Tatro J.B. Alpha-melanocyte stimulating hormone suppresses intracerebral tumor necrosis factor-alpha and interleukin-1beta gene expression following transient cerebral ischemia in mice. Neurosci Lett 334 (2002) 186-190
52. Huh S.K., Lipton J.M., and Batjer H.H. The protective effects of alpha-melanocyte stimulating hormone on canine brain stem ischemia. Neurosurgery 40 (1997) 132-139
53. Humphreys M.H. Gamma-MSH, sodium metabolism, and salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol 286 (2004) R417-R430
54. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88 (1997) 131-141
55. Hwang I.K., Yoo K.Y., Park J.K., Nam Y.S., Lee I.S., Kang J.H., et al. Ischemia-related changes of adrenocorticotropic hormone immunoreactivity and its protective effect in the gerbil hippocampus after transient forebrain ischemia. Neuroscience 126 (2004) 871-877
56. Ichiyama T., Sakai T., Catania A., Barsh G.S., Furukawa S., and Lipton J.M. Systemically administered alpha-melanocyte-stimulating peptides inhibit NF-kappaB activation in experimental brain inflammation. Brain Res 836 (1999) 31-37
57. Ichiyama T., Zhao H., Catania A., Furukawa S., and Lipton J.M. Alpha-melanocyte-stimulating hormone inhibits NF-kappaB activation and IkappaBalpha degradation in human glioma cells and in experimental brain inflammation. Exp Neurol 157 (1999) 359-365
58. Jo S.K., Yun S.Y., Chang K.H., Cha D.R., Cho W.Y., Kim H.K., et al. Alpha-MSH decreases apoptosis in ischaemic acute renal failure in rats: possible mechanism of this beneficial effect. Nephrol Dial Transplant 16 (2001) 1583-1591
59. Joosten E.A., Majewska B., Houweling D.A., Bär P.R., and Gispen W.H. Alpha-melanocyte stimulating hormone promotes regrowth of injured axons in the adult rat spinal cord. J Neurotrauma 16 (1999) 543-553
60. Joseph S.A., Tassorelli C., Prasad A.V., and Lynd-Balta E. NF-kappa B transcription factor subunits in rat brain: colocalization of p65 and alpha-MSH. Peptides 17 (1996) 655-664
61. Karin M. Mitogen activated protein kinases as targets for development of novel anti-inflammatory drugs. Ann Rheum Dis 63 (2004) ii62-ii64
62. Khong K., Kurtz S.E., Sykes R.L., and Cone R.D. Expression of functional melanocortin-4 receptor in the hypothalamic GT1-1 cell line. Neuroendocrinology 74 (2001) 193-201
63. Kishi T., Aschkenasi C.J., Lee C.E., Mountjoy K.G., Saper C.B., and Elmquist J.K. Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat. J Comp Neurol 457 (2003) 213-235
64. Labbé O., Desarnaud F., Eggerickx D., Vassart G., and Parmentier M. Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues. Biochemistry 33 (1994) 4543-4549
65. Lam C.W., and Getting S.J. Melanocortin receptor type 3 as a potential target for anti-inflammatory therapy. Curr Drug Targets Inflamm Allergy 3 (2004) 311-315
66. Lechan R.M., and Fekete C. Role of melanocortin signaling in the regulation of the hypothalamic-pituitary-thyroid (HPT) axis. Peptides 27 (2006) 310-325
67. Lechan R.M., and Tatro J.B. Hypothalamic melanocortin signalling in cachexia. Endocrinology 142 (2001) 3288-3291
68. Lee S.Y., Jo S.K., Cho W.Y., Kim H.K., and Won N.H. The effect of alpha-melanocyte-stimulating hormone on renal tubular cell apoptosis and tubulointerstitial fibrosis in cyclosporine A nephrotoxicity. Transplantation 78 (2004) 1756-1764
69. Lerner A.B., and McGuire J.S. Effect of alpha- and beta-melanocyte stimulating hormones on the skin colour of man. Nature 189 (1961) 176-179
70. Lindberg C., Hjorth E., Post C., Winblad B., and Schultzberg M. Cytokine production by a human microglial cell line: effects of beta-amyloid and alpha-melanocyte-stimulating hormone. Neurotox Res 8 3/4 (2005) 267-276
71. Lipton J.M., and Catania A. Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH. Immunol Today 18 (1997) 140-145
72. Lipton J.M., Macaluso A., Hiltz M.E., and Catania A. Central administration of the peptide alpha-MSH inhibits inflammation in the skin. Peptides 12 (1991) 795-798
73. Liu G., Liu L., Lin C., Tseng J., Chuang M., Lam H., et al. Gene transfer of pro-opiomelanocortin prohormone suppressed the growth and metastasis of melanoma: involvement of α-melanocyte-stimulating hormone-mediated inhibition of the nuclear factor κB/cyclooxygenase-2 pathway. Mol Pharmacol 69 (2006) 440-451
74. Liu H., Kishi T., Roseberry A.G., Cai X., Lee C.E., Montez J.M., et al. Transgenic mice expressing green fluorescent protein under the control of the melanocortin-4 receptor promoter. J Neurosci 23 (2003) 7143-7154
75. Ludbrook J., and Ventura S. ACTH(1-24) blocks the decompensatory phase of the haemodynamic response to acute hypovolaemia in conscious rabbits. Eur J Pharmacol 275 (1995) 267-275
76. Luger T.A., Scholzen T.E., Brzoska T., and Böhm M. New insights into the functions of alpha-MSH and related peptides in the immune system. Ann NY Acad Sci 994 (2003) 133-140
77. Lyson K., and McCann S.M. Alpha-melanocyte-stimulating hormone abolishes IL-1- and IL-6-induced corticotropin-releasing factor release from the hypothalamus in vitro. Neuroendocrinology 58 (1993) 191-195
78. Maaser C., Kannengiesser K., and Kucharzik T. Role of the melanocortin system in inflammation. Ann NY Acad Sci 1072 (2006) 123-134
79. Macaluso A., McCoy D., Ceriani G., Watanabe T., Biltz J., Catania A., et al. Antiinflammatory influences of alpha-MSH molecules: central neurogenic and peripheral actions. J Neurosci 14 (1994) 2377-2382
80. Manna S.K., and Aggarwal B.B. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents. J Immunol 161 (1998) 2873-2880
81. Marks D.L., Butler A.A., Turner R., Brookhart G., and Cone R.D. Differential role of melanocortin receptor subtypes in cachexia. Endocrinology 144 (2003) 1513-1523
82. Martin L.W., and Lipton J.M. Acute phase response to endotoxin: rise in plasma alpha-MSH and effects of alpha-MSH injection. Am J Physiol 259 (1990) R768-R772
83. Martin W.J., McGowan E., Cashen D.E., Gantert L.T., Drisko J.E., Hom G.J., et al. Activation of melanocortin MC(4) receptors increases erectile activity in rats ex copula. Eur J Pharmacol 454 (2002) 71-79
84. Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 63 (2004) 901-910
85. Montminy M. Transcriptional regulation by cyclic AMP. Annu Rev Biochem 66 (1997) 807-822
86. Mountjoy K.G., Guan J., Elia C.J., Sirimanne E.S., and Williams C.E. Melanocortin-4 receptor messenger RNA expression is up-regulated in the non-damaged striatum following unilateral hypoxic-ischaemic brain injury. Neuroscience 89 (1999) 183-190
87. Mountjoy K.G., Mortrud M.T., Low M.J., Simerly R.B., and Cone R.D. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 8 (1994) 1298-1308
88. Mountjoy K.G., Robbins L.S., Mortrud M.T., and Cone R.D. The cloning of a family of genes that encode the melanocortin receptors. Science 257 (1992) 1248-1251
89. Muceniece R., Zvejniece L., Vilskersts R., Liepinsh E., Baumane L., Kalvinsh I., et al. Functional evaluation of THIQ, a melanocortin 4 receptor agonist, in models of food intake and inflammation. Basic Clin Pharmacol Toxicol 101 (2007) 416-420
90. Muñoz-Fernandez M.A., and Fresno M. The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog Neurobiol 56 (1998) 307-340
91. Nakanishi S., Inoue A., Kita T., Nakamura M., Chang A.C.Y., Cohen S.N., et al. Nucleotide sequence of cloned cDNA for bovine corticotropin-β-lipotropin precursor. Nature 278 (1979) 423-427
92. Namba K., Kitaichi N., Nishida T., and Taylor A.W. Induction of regulatory T cells by the immunomodulating cytokines alpha-melanocyte-stimulating hormone and transforming growth factor-beta2. J Leukoc Biol 72 (2002) 946-952
93. Neumann Andersen G., Nagaeva O., Mandrika I., Petrovska R., Muceniece R., Mincheva-Nilsson L., et al. MC(1) receptors are constitutively expressed on leucocyte subpopulations with antigen presenting and cytotoxic functions. Clin Exp Immunol 126 (2001) 441-446
94. Neumann M., Grieshammer T., Chuvpilo S., Kneitz B., Lohoff M., Schimpl A., et al. RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J 14 (1995) 1991-2004
95. Ng T.F., Kitaichi N., and Taylor A.W. In vitro generated autoimmune regulatory T cells enhance intravitreous allogeneic retinal graft survival. Invest Ophthalmol Vis Sci 48 (2007) 5112-5117
96. Nishida T., and Taylor A.W. Specific aqueous humor factors induce activation of regulatory T cells. Invest Ophthalmol Vis Sci 40 (1999) 2268-2274
97. Ollivier V., Parry G.C., Cobb R.R., de Prost D., and Mackman N. Elevated cyclic AMP inhibits NF-kappaB-mediated transcription in human monocytic cells and endothelial cells. J Biol Chem 271 (1996) 20828-20835
98. Papadopoulos A.D., and Wardlaw S.L. Endogenous alpha-MSH modulates the hypothalamic-pituitary-adrenal response to the cytokine interleukin-1beta. J Neuroendocrinol 11 (1999) 315-319
99. Persengiev S.P., and Green M.R. The role of ATF/CREB family members in cell growth, survival and apoptosis. Apoptosis 8 (2003) 225-228
100. Pritchard L.E., Turnbull A.V., and White A. Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. J Endocrinol 172 (2002) 411-421
101. Raap U., Brzoska T., Sohl S., Päth G., Emmel J., Herz U., et al. Alpha-melanocyte-stimulating hormone inhibits allergic airway inflammation. J Immunol 171 (2003) 353-359
102. Rajora N., Ceriani G., Catania A., Star R.A., Murphy M.T., and Lipton J.M. Alpha-MSH production, receptors, and influence on neopterin in a human monocyte/macrophage cell line. J Leukoc Biol 59 (1996) 248-253
103. Roselli-Rehfuss L., Mountjoy K.G., Robbins L.S., Mortrud M.T., Low M.J., Tatro J.B., et al. Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci USA 90 (1993) 8856-8860
104. Scholzen T.E., Sunderkötter C., Kalden D.H., Brzoska T., Fastrich M., Fisbeck T., et al. Alpha-melanocyte stimulating hormone prevents lipopolysaccharide-induced vasculitis by down-regulating endothelial cell adhesion molecule expression. Endocrinology 144 (2003) 360-370
105. Selkirk J.V., Nottebaum L.M., Lee J., Yang W., Foster A.C., and Lechner S.M. Identification of differential melanocortin 4 receptor agonist profiles at natively expressed receptors in rat cortical astrocytes and recombinantly expressed receptors in human embryonic kidney cells. Neuropharmacology 52 (2007) 459-466
106. Shalts E., Feng Y.J., Ferin M., and Wardlaw S.L. Alpha-melanocyte-stimulating hormone antagonizes the neuroendocrine effects of corticotropin-releasing factor and interleukin-1 alpha in the primate. Endocrinology 131 (1992) 132-138
107. Siebenlist U., Franzoso G., and Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 10 (1994) 405-455
108. Sinha P.S., Schiöth H.B., and Tatro J.B. Roles of the melanocortin-4 receptor in antipyretic and hyperthermic actions of centrally administered α-MSH. Brain Res 1001 (2004) 150-158
109. Slominski A., Ermark G., and Mihn M. ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are present in skin. J Clin Endocrinol Metab 81 (1996) 2746-2749
110. Star R.A., Rajora N., Huang J., Stock R.C., Catania A., and Lipton J.M. Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proc Natl Acad Sci USA 92 (1995) 8016-8020
111. Sutton G.M., Duos B., Patterson L.M., and Berthoud H.R. Melanocortinergic modulation of cholecystokinin-induced suppression of feeding through extracellular signal-regulated kinase signaling in rat solitary nucleus. Endocrinology 146 (2005) 3739-3747
112. Taherzadeh S., Sharma S., Chhajlani V., Gantz I., Rajora N., Demitri M.T., et al. Alpha-MSH and its receptors in regulation of tumor necrosis factor-alpha production by human monocyte/macrophages. Am J Physiol 276 (1999) R1289-R1294
113. Tatro J.B., Entwistle M.L., Fairchild-Huntress V., and Huszar D. MC4-R is the principal melanocortin receptor subtype of the preoptic area and lateral hypothalamus. Abstr-Soc Neurosci 27 (2001) 310.2
114. Tatro J.B. Endogenous antipyretics. Clin Infect Dis 31 Suppl. 5 (2000) S190-201
115. Taylor A.W. The immunomodulating neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) suppresses LPS-stimulated TLR4 with IRAK-M in macrophages. J Neuroimmunol 162 (2005) 43-50
116. Turnbull A.V., and Rivier C.L. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 79 (1999) 1-71
117. Vaisse C., Clement K., Durand E., Hercberg S., Guy-Grand B., and Froguel P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 106 (2000) 253-262
118. Van der Ploeg L.H., Martin W.J., Howard A.D., Nargund R.P., Austin C.P., Guan S., et al. A role for the melanocotin 4 receptor in sexual function. Proc Natl Acad Sci USA 99 (2002) 11381-11386
119. Vila N., Castillo J., Dávalos A., Esteve A., Planas A.M., and Chamorro A. Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke 34 (2003) 671-675
120. Vongs A., Lynn N.M., and Rosenblum C.I. Activation of MAP kinase by MC4-R through PI3 kinase. Regul Pept 120 (2004) 113-118
121. Vulliémoz N.R., Xiao E., Xia-Zhang L., Ferin M., and Wardlaw S.L. Melanocortin modulation of inflammatory cytokine and neuroendocrine responses to endotoxin in the monkey. Endocrinology 147 (2006) 1878-1883
122. Wachira S.J., Hughes-Darden C.A., Nicholas Jr. H.B., Taylor C.V., and Robinson T.J. Neural melanocortin receptors are differentially expressed and regulated by stress in rat hypothalamic-pituitary-adrenal axis. Cell Mol Biol 50 (2004) 703-713
123. Wang P., Wu P., Siegel M.I., Egan R.W., and Billah M.M. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. J Biol Chem 270 (1995) 9558-9563
124. Wikberg J.E., Muceniece R., Mandrika I., Prusis P., Lindblom J., Post C., et al. New aspects on the melanocortins and their receptors. Pharmacol Res 42 5 (2000) 393-420
125. Wong K.Y., Rajora N., Boccoli G., Catania A., and Lipton J.M. A potential mechanism of local anti-inflammatory action of alpha-melanocyte-stimulating hormone within the brain: modulation of tumor necrosis factor-alpha production by human astrocytic cells. Neuroimmunomodulation 4 (1997) 37-41
126. Xia Y., Wikberg J.E.S., and Chhajlani V. Expression of melanocortin 1 receptor in periaqueductal gray matter. Mol Neurosci 6 (1995) 2193-2196
127. Xiao E., Xia-Zhang L., Vulliémoz N.R., Ferin M., and Wardlaw S.L. Agouti-related protein stimulates the hypothalamic-pituitary-adrenal (HPA) axis and enhances the HPA response to interleukin-1 in the primate. Endocrinology 144 (2003) 1736-1741
128. Yin P., Luby T.M., Chen H., Etemad-Moghadam B., Lee D., Aziz N., et al. Generation of expression constructs that secrete bioactive alphaMSH and their use in the treatment of experimental autoimmune encephalomyelitis. Gene Ther 10 (2003) 348-355
129. Zelazowski P., Patchev V.K., Zelazowska E.B., Chrousos G.P., Gold P.W., and Sternberg E.M. Release of hypothalamic corticotropin-releasing hormone and arginine-vasopressin by interleukin 1 beta and alpha MSH: studies in rats with different susceptibility to inflammatory disease. Brain Res 631 (1993) 22-26
130. Zhong H., SuYang H., Erdjument-Bromage H., Tempst P., and Ghosh S. The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89 (1997) 413-424